Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Olivier Rascol, MD, PhD
Toulouse University Hospital, France
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
103 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Medical University Innsbruck
Innsbruck, Austria
- Chu de Tivoli
La Louvière, Belgium
- Neurologicka Klinika Fakutni Nemocnice Sv. Anny V Brne
Brno, Czechia
- Axon Clinical S.R.O.
Prague, Czechia
- Hopital Neurologique
Bron, France
- Hopital Gabriel Montpied
Clermont-Ferrand, France
- Chu Nantes-Hopital Laennec
Nantes, France
- Chu de Nice Hpital Pasteur
Nice, France
- Chu Caremeau
Nîmes, France
- Hopital Purpan
Toulouse, France
- University of Pecs, Clinical Center
Pécs, Hungary
- Hadassah Medical Center, Ein Kerem
Jerusalem, Israel
- Shaare Zedek Medical Center
Jerusalem, Israel
- Galilee Medical Center- Nahariya
Nahariya, Israel
- Rabin Medical Center, Beilinson Hospital
Petah Tikva, Israel
- Chaim Sheba Medical Center
Ramat Gan, Israel
- Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
- Casa Di Cura Villa Margherita
Arcugnano, Italy
- Centro Ricerca Parkinson San Raffaele Cassino
Cassino, Italy
- University Chieti Cesi Met Clinical Research Center-Crc
Chieti, Italy
- Ospedale Di Grosseto, Azienda Usl Toscana Sud Est
Grosseto, Italy
- Istituto Clinico Humanitas - Irccs
Milan, Italy
- Aou University of Campania "luigi Vanvitelli"
Naples, Italy
- Irccs Fondazione C. Mondino
Pavia, Italy
- Irccs San Raffaele Pisana
Roma, Italy
- Irccs Santa Lucia Foundation
Rome, Italy
- Policlinico Tor Vergata - Uosd Parkinson
Rome, Italy
- University of Amsterdam
Amsterdam, Netherlands
- Krakowska Akademia Neurologii Sp. Z O. O
Krakow, Poland
- Neuroklinika Gabinet Lekarski Prof. Andrzej Bogucki
Lodz, Poland
- Neuro-Care Sp Z O. O.
Siemianowice Śląskie, Poland
- Oddział Neurologii Ul. L. Kondratowicza 8
Warsaw, Poland
- Hospital Braga
Braga, Portugal
- Cns - Campus Neurologico Senior
Torres Vedras, Portugal
- Kazan State Medical University
Kazan', Russia
- Federal Siberian Scientic Clinical Center of Fmba
Krasnoyarsk, Russia
- Novosibirsk Regional Specialized Scientific-Practical Neurological Center on the Basis City Clinical Hospital 34
Novosibirsk, Russia
- the First Saint-Petersburg State Medical University Named After Ip Pavlov
Saint Petersburg, Russia
- Siberian State Medical University
Tomsk, Russia
- Nemocnica Akad. L. Derera
Bratislava, Slovakia
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2019
- Primary completion
- 1 Nov 2022
- Completion
- 28 Feb 2027
- Last update posted
- 21 May 2025
- Registered enrollment
- 381
- Registry id
- NCT04006210
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.